- Home
- MAN vs NVCR Comparison
MAN vs NVCR Comparison
Compare MAN & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAN
- NVCR
- Stock Information
- Founded
- MAN 1948
- NVCR 2000
- Country
- MAN United States
- NVCR Jersey
- Employees
- MAN N/A
- NVCR N/A
- Industry
- MAN Professional Services
- NVCR Medical/Dental Instruments
- Sector
- MAN Consumer Discretionary
- NVCR Health Care
- Exchange
- MAN Nasdaq
- NVCR Nasdaq
- Market Cap
- MAN 2.9B
- NVCR 3.0B
- IPO Year
- MAN 1988
- NVCR 2015
- Fundamental
- Price
- MAN $58.61
- NVCR $33.54
- Analyst Decision
- MAN Hold
- NVCR Buy
- Analyst Count
- MAN 6
- NVCR 5
- Target Price
- MAN $76.60
- NVCR $33.40
- AVG Volume (30 Days)
- MAN 578.5K
- NVCR 1.8M
- Earning Date
- MAN 01-28-2025
- NVCR 10-30-2024
- Dividend Yield
- MAN 5.24%
- NVCR N/A
- EPS Growth
- MAN N/A
- NVCR N/A
- EPS
- MAN 0.78
- NVCR N/A
- Revenue
- MAN $18,084,700,000.00
- NVCR $577,738,000.00
- Revenue This Year
- MAN N/A
- NVCR $19.13
- Revenue Next Year
- MAN $1.14
- NVCR $5.33
- P/E Ratio
- MAN $75.42
- NVCR N/A
- Revenue Growth
- MAN N/A
- NVCR 14.63
- 52 Week Low
- MAN $58.74
- NVCR $11.70
- 52 Week High
- MAN $80.25
- NVCR $34.00
- Technical
- Relative Strength Index (RSI)
- MAN 34.03
- NVCR 71.04
- Support Level
- MAN $58.74
- NVCR $31.45
- Resistance Level
- MAN $61.21
- NVCR $34.00
- Average True Range (ATR)
- MAN 1.28
- NVCR 2.49
- MACD
- MAN -0.24
- NVCR 0.45
- Stochastic Oscillator
- MAN 5.26
- NVCR 92.37
About MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that includes Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives maximum of the company's revenue. The company derives maximum geographical revenue from Southern European region.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.